|
Khare, S D; Lee, S; Bull, M J et al. (2001) Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides. Clin Immunol 98:364-9
|
|
Lee, S; Khare, S D; Griffiths, M M et al. (2000) HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease. Hum Immunol 61:140-7
|
|
Khare, S D; Lee, S; Bull, M J et al. (1999) Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice. Hum Immunol 60:116-26
|
|
Khare, S D; Bull, M J; Hanson, J et al. (1998) Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol 160:101-6
|
|
Khare, S D; Luthra, H S; David, C S (1998) Animal models of human leukocyte antigen B27-linked arthritides. Rheum Dis Clin North Am 24:883-94, xi-xii
|
|
Khare, S D; Luthra, H S; David, C S (1998) Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice. Semin Immunol 10:15-23
|
|
Khare, S D; Luthra, H S; David, C S (1996) Role of HLA-B27 in spondyloarthropathies. Curr Top Microbiol Immunol 206:85-100
|
|
Khare, S D; Hansen, J; Luthra, H S et al. (1996) HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest 98:2746-55
|
|
Khare, S D; Luthra, H S; David, C S (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 182:1153-8
|
|
Pedrinaci, S; Hanson, J; David, C (1994) Hierarchy in the assembly of HLA-B27 and HLA-Cw3 molecules in transgenic mice. Immunogenetics 39:130-7
|
Showing the most recent 10 out of 18 publications
